Fulgent Genetics, Inc. (BMV:FLGT)
Mexico · Delayed Price · Currency is MXN 492.50
+42.50 (9.44%)
At close: Jan 7, 2026
Fulgent Genetics Revenue
Fulgent Genetics had revenue of $84.07M USD in the quarter ending September 30, 2025, with 17.18% growth. This brings the company's revenue in the last twelve months to $315.55M, up 13.60% year-over-year. In the year 2024, Fulgent Genetics had annual revenue of $283.47M, down -1.99%.
Revenue (ttm)
$315.55M
Revenue Growth
+13.60%
P/S Ratio
2.60
Revenue / Employee
$240.33K
Employees
1,313
Market Cap
15.06B MXN
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 283.47M | -5.74M | -1.99% |
| Dec 31, 2023 | 289.21M | -329.76M | -53.27% |
| Dec 31, 2022 | 618.97M | -373.62M | -37.64% |
| Dec 31, 2021 | 992.58M | 570.87M | 135.37% |
| Dec 31, 2020 | 421.71M | 389.18M | 1,196.46% |
| Dec 31, 2019 | 32.53M | 11.18M | 52.35% |
| Dec 31, 2018 | 21.35M | 2.62M | 13.99% |
| Dec 31, 2017 | 18.73M | 454.00K | 2.48% |
| Dec 31, 2016 | 18.28M | 8.70M | 90.85% |
| Dec 31, 2015 | 9.58M | 8.30M | 649.30% |
| Dec 31, 2014 | 1.28M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Orbia Advance Corporation | 138.01B |
| Grupo Nacional Provincial, S.A.B. | 113.71B |
| Grupo Herdez | 38.60B |
| Grupo Gigante, S. A. B. de C. V. | 35.74B |
| Grupo Profuturo | 31.87B |
| Sitios Latinoamérica | 16.72B |
| Vinte Viviendas Integrales | 13.21B |
| FIBRA Macquarie México | 5.00B |